Thus, CD57+ cells should be measured not for the diagnosis of Lyme disease but for the indication of chronic exposure to antigens that originate from bacteria, viruses, tumor cells, and neoantigens formed in the body. This evidence concerns the gene B3GAT1 and neoplasm.